It's a good question. I know the people whom I work with intimately at the lab at McMaster are very innovative. They have a lot of capacity to deal with this type of testing. The reality is there's a hierarchy of needs. The highest priority in the hierarchy of needs currently is people who are symptomatic with COVID-19, people who are exposed to COVID-19, long-term care outbreaks and hospitalized patients. With turnaround time still not being adequate for many individuals, it's a question of whether or not you want to expand capacity without the ability to expand and flex that capacity in that sense.
But I agree. There are lots of different ways to innovate it. My colleagues at McMaster whom you just chatted with have looked at different mechanisms in pooling, in robots, in other methodologies to get testing scaled up to a quantification that—